您的位置: 首页 > 农业专利 > 详情页

BCL6 inhibitors as anticancer agents
专利权人:
发明人:
Ari Melnick,Leandro Carlos A. Cerchietti,Mariano G. Cardenas,Fengtian Xue,Alexander D. MacKerell
申请号:
US14899083
公开号:
US09943506B2
申请日:
2014.06.16
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention provides compositions and methods for blocking the BCL6 BTB domain with small molecule, non-peptide compounds as disclosed and claimed herein. BCL6 is a transcriptional repressor of the BTB-POZ (brie a brae, tramtrack, broad complex/pox virus zincfinger) family of proteins. It is required for normal development of germinal center (GC) B-cells and is also the most commonly involvedoncogene in diffuse large B-celllymphomas (DLBCLs), and constitutive expression of BCL6 in GC B-cells causes DLBCL in mice.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充